Bromide

Bromide

SCHEMBL5484073

Br.CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1cc(C(C)C)c3c(c1)N(C)CCO3)C2

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F2R P25116 6/20 0.60
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1730010 0.92 F2R (0.59) F2R
Bromide SCHEMBL5489245 0.90 F2R (0.54) F2R
Bromide SCHEMBL1728675 0.89 F2R (0.72) F2RTSHR
SCHEMBL14449099 0.88 F2R (0.71) F2RTSHR
Bromide SCHEMBL1731180 0.84 F2R (0.72) F2R
SCHEMBL27505356 0.83 F2R (0.43) F2R
Bromide SCHEMBL1731432 0.83 F2R (0.80) F2R
Bromide SCHEMBL1729713 0.83 F2R (0.70) F2R
Bromide SCHEMBL1731766 0.82 F2R (0.72) F2R
Bromide SCHEMBL1731452 0.82 F2R (0.52) F2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007509892-A 2007-04-19 JP claimed
EP-1678153-A1 THIOZOLIDINONES, PRODUCTION AND USE THEREOF AS MEDICAMENTS Schering Aktiengesellschaft (DE) 2006-07-12 EP claimed
WO-2005042505-A1 THIOZOLIDINONES, PRODUCTION AND USE THEREOF AS MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2005-05-12 WO claimed
EP-1391451-A1 2-IMINOPYRROLIDINE DERIVATES Eisai Co., Ltd. (JP) 2004-02-25 EP disclosed